The most expensive option isn't always the right one

There’s a reflex that sometimes kicks in when a claims team hears a policyholder has suffered a serious medical emergency overseas. The mental price tag goes up, and usually settles somewhere around a dedicated air ambulance home, under full medical escort, at considerable cost. Sometimes that is precisely what the situation demands. Often it is not, and the space between those two outcomes is where a great deal of cost quietly goes.

To be clear - the point of this is certainly not that the cheaper option is usually better. It’s that good clinical decisions and cost mitigation are frequently the same thing, and the difference depends almost entirely on having the clinical depth and attention to detail to look past the worst-case assumption, rather than simply pay for it.

A recent case

A passenger suffered a cardiac arrest and was successfully resuscitated. At that first moment, the assumption shared by almost everyone involved was the obvious one: this would be a costly repatriation under full medical escort, quite possibly by air ambulance.

But a cardiac arrest is a symptom, not a diagnosis, and the right next step was investigation rather than immediate evacuation or repatriation. Once the clinical picture was properly worked up, it didn’t support the worst-case reading. The patient's heart was found to be structurally normal, and the appropriate device was fitted to manage the risk of a future event. After a suitable period of observation, the patient flew home safely on a commercial flight, without a medical escort.

The difference in cost between what was first assumed and what actually happened was significant. But it’s worth being clear about the order in which that came about. The clinical decision was made first, on its own merits. The cost outcome followed from it. Nobody chose a cheaper option; the clinically correct path simply turned out to cost a fraction of the default, because the default is set by uninformed caution, rather than by the facts of the case.

Why this is an underwriting issue, not just a clinical one

That distinction is easy to state and hard to deliver. It only works if the people managing the case have the clinical seniority to challenge a frightening-sounding presentation, the diagnostic access to establish what is actually going on, and the confidence to stand behind a decision that departs from the cautious default. Take any of those away and the safe institutional choice is to pay for the worst case every time, whether or not the case warrants it.

This is what proactive case management means once you look past the phrase. Managed well, an alarming emergency becomes a controlled, well-evidenced sequence of decisions. Managed by default, the same emergency becomes a maximum-cost claim regardless of what the clinical facts would have supported. The difference between those two approaches is not a rounding error.

For underwriters and claims managers, the practical question to ask of any medical assistance partner is a simple one. When an expensive assumption is on the table, who has the clinical authority to test it, and are they willing to?

Clinical details in this case have been generalised and anonymised. Every repatriation decision is made on its own clinical facts, and no two cases are alike. This account is illustrative of an approach, not a clinical protocol.